Cannaus
  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Cannaus

Zelira Therapeutics launches clinical trial on medical cannabis for retired athletes

4 years ago
in National
0
High resolution cannabis background

High resolution cannabis background

Share on FacebookShare on Twitter

Medical cannabis company Zelira Therapeutics (ASX:ZLD) has launched a new clinical trial that will treat retired athletes suffering from chronic pain with medical cannabis.

Zelira announced the new trial on Thursday. The company is conducting its research alongside partner Levin Health, a Melbourne-based medical cannabis company specialising in developing clinical evidence-backed cannabis medications. 

According to the ASX release published by Zelira, the company has licensed their proprietary ZTL-106 cannabinoid formulation to Levin health for the research. Zelira will test the formulation’s effectiveness on a group of retired professional and amateur athletes who suffer from chronic pain. 

Zelira Therapeutics Logo

The two medical cannabis companies have also entered into a project management agreement. This agreement will see Levin Health fund the clinical trial and pay Zelira to manage it. Levin Health will also contribute to the study’s advisory board and patient base. The two companies will split any commercial profits. 

The companies have also chosen to divide marketing rights for ZTL-106 if the formulation proves effective. Zelira will have marketing rights for North and South America, and Levin will hold the rights for the rest of the world.  

According to Levin Health’s Chief Executive Officer Mark Brayshaw, the company has high hopes that the trial will show that their medical cannabis formulation works for athletes. 

Chronic pain is one of the major health issues facing not just athletes, but active Australians, and we have high hopes for the trial.

While the study is limited to athletes, more and more Australians are turning to medical cannabis to manage chronic pain. Research from the Australian Institute of Health and Welfare shows that 1 in 5 Australians over the age of forty-five suffer from chronic pain. That’s over 1.6 million people. In 2018, chronic pain conditions cost Australia over $139 billion in productivity losses and reduced quality of life. 

After the new study was announced, shares in Zelira rose to a high of $0.54 on Thursday. The company is also conducting a clinical trial on medical cannabis and Autism. 

Zelira and Levin Health’s trial will be conducted at La Trobe University’s Sport and Exercise Medicine Research Centre in Victoria. The trial will begin shortly. 

Tags: Research
Share8Tweet5
Karie Cornell

Karie Cornell

Based in Victoria, Karie's passionate about pro-cannabis legislation in Australia. She joined Cannaus to share and bring awareness to the latest cannabis news across Australia.

Related Posts

Cannabis leaf with seeds
National

WA government classifies a cannabis seed the same as a fully-grown plant

January 13, 2022
Small cannabis plant growing in a pot
National

New Zealand-based cannabis producer Greenfern reaches partnership agreement with Cannvalate

January 13, 2022
Cannabis medicine
National

Study shows the majority of women using medical cannabis for endometriosis obtain it illegally

January 11, 2022
Green cannabis leaf on wood
National

Cannim set to become major name in adult-use cannabis market through strategic merger

December 27, 2021
Cannabis oil with bud
National

Elixinol Wellness (ASX: EXL) signs deal with major British cannabis company

December 27, 2021
Penalty
National

TGA fines St Francis Pharmacy nearly $40k for advertising medicinal cannabis

December 23, 2021
Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address
  • Home
  • Contact
  • Privacy Policy

Disclaimer
Cannaus does not recommend that anyone uses cannabis for medical or adult use purposes unless consulted by a medical professional. Cannabis is a drug and may have negative side effects. Please consult with your doctor to find out if cannabis is right for you.

  • Home
  • State News
    • ACT
    • QLD
    • NSW
    • NT
    • SA
    • TAS
    • VIC
    • WA
  • Topics
    • Business
    • CBD
    • Government
    • Hemp
    • International
    • Legalisation
    • Medicinal Cannabis
    • Offences
    • Research
    • Misc
  • Cannabis Companies
No Result
View All Result
Weekly Cannabis News

Get the latest Australian cannabis news straight to your inbox every week.

Enter your email address

Thanks, I’m not interested

wpDiscuz